Open AccessCOVID-19 pandemic: do we need systematic screening of patients with cardiovascular risk factors in Low and Middle-Income Countries (LMICs) for preventing death?
Author(s) -
Mazou Ngou Temgoua,
Liliane Mfeukeu Kuaté,
William Ngatchou,
Aurélie T. Sibetcheu,
Zouliatou Nzina Toupendi,
Grace Belobo,
Alice Ossa,
Samuel Kingué
Publication year - 2020
Publication title -
the pan african medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.287
H-Index - 30
ISSN - 1937-8688
DOI - 10.11604/pamj.2020.35.2.22947
Subject(s) - medicine , pandemic , covid-19 , incidence (geometry) , intensive care medicine , cause of death , low and middle income countries , clinical trial , risk factor , disease , virology , outbreak , developing country , infectious disease (medical specialty) , physics , optics , economics , economic growth
COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many proposed drugs are under clinical trials. Considering the high incidence of thromboembolic events in critically ill patients with COVID-19, prevention of this disorder should be essential in order to reduce mortality in these patients.